Stay updated on Acalabrutinib in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib in Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The study record for the Phase 2 ovarian cancer trial is displayed, including its eligibility criteria, treatment arms, outcome measures, locations, and record documents. It indicates the study is completed and is no longer recruiting participants.
    Difference
    42%
    Check dated 2026-11-07T11:17:50.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the study page remains unavailable with a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T10:20:45.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T11:18:47.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T12:07:02.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site footer revision number changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T12:55:31.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now shows a 403 error, replacing the usual study record content with a generic header and navigation. Consequently, readers cannot access the trial information or submission history on this page.
    Difference
    17%
    Check dated 2026-09-19T22:12:00.000Z thumbnail image

Stay in the know with updates to Acalabrutinib in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.